Quick answers
- What is Insulin Diluting Medium for NovoLog?
- Insulin Diluting Medium for NovoLog is a brand name of Water, a prescription medicine. The FDA NDC Directory lists 1 Insulin Diluting Medium for NovoLog product in 1 strength and form.
- Who makes Insulin Diluting Medium for NovoLog?
- Novo Nordisk Inc holds the FDA application for Insulin Diluting Medium for NovoLog (BLA020986, approved June 7, 2000).
- Is there a generic or store brand of Insulin Diluting Medium for NovoLog?
- Yes. The FDA NDC Directory lists 17 other products with the same active ingredients, strength and form as a Insulin Diluting Medium for NovoLog product, 6 of them generic. Ask your pharmacist whether one is right for you.
- Has Insulin Diluting Medium for NovoLog been recalled?
- FDA enforcement reports list 2 recalls of Insulin Diluting Medium for NovoLog products; the newest started March 22, 2021. A recall usually concerns specific lots, not every product.
What Insulin Diluting Medium for NovoLog is
Each Insulin Diluting Medium for NovoLog product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Water · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| water 100% injection, solution (intravenous, subcutaneous) | Insulin Diluting Medium for NovoLog | 17 products, 15 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Water →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA020986 | Novo Nordisk Inc | June 7, 2000 | 1 |
Companies that list Insulin Diluting Medium for NovoLog
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Insulin Diluting Medium for NovoLog products.
- Novo Nordisk1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 22, 2021 · Class I · Terminated · D-0615-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit) — Novo Nordisk Inc
-
March 22, 2021 · Class I · Terminated · D-0616-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90 — Novo Nordisk Inc
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.